Cited by 112Mesenchymal stem cell researchLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Mesenchymal stem cell infusion therapy in a carbon tetrachloride‐induced liver fibrosis model affects matrix metalloproteinase expression

Rabani, Vahideh, Shahsavani, Mansoureh, Gharavi, Marzieh, Piryaei, Abbas, Azhdari, Zahra, Baharvand, Hossein·2010·Cell Biology International

Abstract

In order to investigate the effects of bone marrow‐derived MSCs (mesenchymal stem cells) in reversing liver fibrosis and to determine their possible mechanism of action, mouse MSCs were infused into the tail vein of a CCl 4 injection mouse chronic model. MSCs caused a decrease in liver fibrosis histopathologically, 4 weeks after transplantation. The reduction in liver collagen was confirmed by quantitative analysis. Moreover, lipid peroxidation in the CCl 4/MSC group decreased significantly. Quantitative RT (reverse transcription)‐PCR analysis showed administration of MSCs has a significant antifibrotic effect as evidenced by the decrease in expression of liver collagen and increase in MMP13 (matrix metalloproteinase 13) in the CCl 4/MSC group when compared with the CCl 4 group, 4 weeks after transplantation. The expression of αSMA (smooth muscle actin) and TIMP1 was also down‐regulated in the CCl 4/MSC group. Additionally, the expression of MMP9 was significantly up‐regulated in the CCl 4‐treated group; however, there was no significant change after MSC injection. Few engrafted cells in the recipient liver and were able to differentiate into albumin‐positive cells. In conclusion, MSCs can enhance recovery of a CCl 4‐injured mouse liver through their influence in reducing collagen deposition by possibly affecting expression of MMPs.

Integrity signals

Registry

Crossref · 10.1042/cbi20090386

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MSCs modulate fibrosis by enhancing expression of MMPs and downregulating TIMPs, resulting in regression of liver fibrosis.

    “Moreover, MSCs can modulate fibrosis by enhancing the expression of matrix metalloproteinases (MMPs) and downregulating the expression of tissue inhibitors of MMPs, resulting in the regression of liver fibrosis [202], [203].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rabani, V., Shahsavani, M., Gharavi, M., Piryaei, A., Azhdari, Z., & Baharvand, H.
Affiliations
  • Royan Institute (IR)
  • Iranian Legal Medicine Organization (IR)
  • University of Science and Culture (IR)
Corresponding author
Baharvand, Hossein
Venue
Cell Biology International
Publisher
Wiley
Published
2010-06
Volume
34
Issue
6
Pages
601-605
ISSN
  • 1065-6995 (ISSN-L)
  • 1095-8355
OpenAlex
W2040041350
Cited by
112
References
27
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 12 · 2016: 5 · 2015: 14 · 2014: 16 · 2013: 6 · 2012: 7
FWCI
2.85
Type
journal article
Language
en
Open access
closed
Locations
  • Cell Biology International (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
mesenchymal stem cells, liver fibrosis, carbon tetrachloride, matrix metalloproteinases, MMP-13, MMP-9, collagen deposition, lipid peroxidation, alpha-smooth muscle actin, TIMP-1, stem cell engraftment, antifibrotic therapy, bone marrow-derived stem cells
MeSH terms
Actins, Animals, Bone Marrow Cells, Carbon Tetrachloride, Collagen, Disease Models, Animal, Female, Liver Cirrhosis, Down-Regulation, Up-Regulation, Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 9, Mesenchymal Stem Cell Transplantation, Mice, Matrix Metalloproteinase 13, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review